About 1,919,498 results (2,895 milliseconds)

Tinnitus relief. Sound therapy - Apps on Google Play

https://play.google.com/store/apps/details?id=com.zdn35.music.songs.audio.tinnitussoundtherapy
Please use headphones for optimal effect. Firstly keep the volume at the level where it seems to be matching your tinnitus then take a minute or two before ...

USRE38115E1 - Dextromethorphan and an oxidase inhibitor for ...

https://patents.google.com/patent/USRE38115E1/en
Methods are disclosed for increasing the effectiveness of dextromethorphan in treating chronic or intractable pain, for treating tinnitus ... This condition does ...

US10589087B2 - Systems and methods for altering brain and body ...

https://patents.google.com/patent/US10589087B2/en
Example 8 describes the successful use of the invention to reduce tinnitus in a subject. In some embodiments, arm bands (electrotactile or vibrotactile) or ...

WO2000055350A1 - Human cancer associated gene sequences ...

https://patents.google.com/patent/WO2000055350A1/en
In a further embodiment, polynucleotides of the invention comprise a portion of the coding sequences, as disclosed herein, but do not comprise all or a portion ...

US20160214981A1 - Fluoro-9-methyl-beta-carbolines - Google ...

https://patents.google.com/patent/US20160214981A1/en
With increasing age the percentage of hearing impaired rises. Even now hearing ... (Va) to 6-fluoro-9-methyl-β-carboline (Ia) under addition of a catalyst ...

US9339216B2 - Systems and methods for the screening and ...

https://patents.google.com/patent/US9339216B2/en
... rate=0.48; false positive rate=0.33) measurement ranges. These are univariate methods that do not include the Dose-Hearing model. The 3 component PLS model ...

WO2009132050A2 - Auris formulations for treating otic diseases ...

https://patents.google.com/patent/WO2009132050A2/en
The fluid-filled inner ear, or auris interna, consists of two major components: the cochlear and the vestibular apparatus. [001O7JThe cochlea is the portion of ...

CA2721927A1 - Auris formulations for treating otic diseases and ...

https://patents.google.com/patent/CA2721927A1/en
refers to the percentage of the administered dose of compounds disclosed ... Hearing loss does not usually occur. [00236] In some instances, vestibular ...

WO2018020263A1 - Cyclobutane derivatives as modulators of ...

https://patents.google.com/patent/WO2018020263A1/en
... give rise to tinnitus. Tinnitus may follow noise- induced hearing loss as a result of adaptive changes in central auditory pathways from brainstem to ...

WO2010085352A2 - Bumetanide, furosemide, piretanide ...

https://patents.google.com/patent/WO2010085352A2/en
About 50 percent of adults older than 60 experience postherpetic neuralgia after shingles, whereas only 10 percent of all people with shingles do. The ...

ES2397852T3 - CGRP peptide antagonists and conjugates - Google ...

https://patents.google.com/patent/ES2397852T3/en
"Polypeptide" and "protein" are used interchangeably herein and include a molecular chain of amino acids linked through peptide bonds. The terms do not refer ...

WO2015044434A2 - Fluor-9-methyl-β-carbolines - Google Patents

https://patents.google.com/patent/WO2015044434A2/en
2,9 Millionen Patienten an Tinnitus. With increasing age, the percentage of the hearing impaired increases. Already today, hearing disorders represent the ...

FI64376C - PHARMACEUTICAL FORM OF PHARMACOLOGICAL ...

https://patents.google.com/patent/FI64376C/en
... percentage sieve with ... The analytical sample was recrystallized (from benzene cyclohexane) to give pure compound Va as colorless crystals, m.p..

US10124062B2 - Methods of treating, inhibiting and/or preventing ...

https://patents.google.com/patent/US10124062B2/en
All experimental protocols were approved by the Institutional Animal Care and Use Committee at the Loma Linda Veteran's Affairs Hospital. When the animals ...

US20200275874A1 - Methods and Automatic System to Identify ...

https://patents.google.com/patent/US20200275874A1/en
A method to identify victim of abuse and remote operator using voice to skull and remote neural monitoring, comprising the steps of: using a database in a ...

Ask Autechre Anything (02-07/11/2013) - Google Drive

https://docs.google.com/spreadsheets/d/1XAizLmKun4yF6oBVUhIrewYN-ZiY_9ORckmT-hF93Ho/edit
Sorry i dont have that, but i do rate talk talk and mark hollis. I think Sean ... when working with tdr, do they give you formal presentations on their ...

US7119061B2 - Dalbavancin compositions for treatment of bacterial ...

https://patents.google.com/patent/US7119061B2/en
Administration and delivery of the drug to the patient, e.g., intravenously, can be done at a controlled rate, so that the concentration in the blood does not ...

EP3189134A1 - Compositions, systems, and methods for generating ...

https://patents.google.com/patent/EP3189134A1/en
... VA, the VA spends over $1 billion on hearing loss compensation. The Navy ... In some embodiments, a composition does not achieve an Effective Release Rate ...

EP0788359B1 - Combination of dextromethorphan with quinidine or ...

https://patents.google.com/patent/EP0788359B1/en
This combination of compositions has proven successful in the treatment of intractable coughing, dermatitis, chronic pain, and tinnitus. Images (1) ...

EP0788359B1 - Combinaison du dextromethorphane avec la ...

https://patents.google.com/patent/EP0788359B1/fr
This condition does not readily respond to non-prescription drugs, lotions, or ointments. ... tinnitus refers to a syndrome characterized by a high-pitched ...